Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vasospasm, Intracranial | 20 | 2024 | 215 | 5.930 |
Why?
|
Stroke | 95 | 2024 | 9758 | 5.780 |
Why?
|
Brain Ischemia | 50 | 2023 | 3049 | 4.570 |
Why?
|
Cerebrovascular Disorders | 13 | 2023 | 1474 | 4.000 |
Why?
|
Vasoconstriction | 19 | 2023 | 592 | 3.480 |
Why?
|
Cerebral Angiography | 23 | 2021 | 1281 | 2.460 |
Why?
|
Vasculitis, Central Nervous System | 8 | 2022 | 45 | 2.260 |
Why?
|
Ischemic Attack, Transient | 10 | 2022 | 882 | 2.000 |
Why?
|
Posterior Leukoencephalopathy Syndrome | 4 | 2023 | 50 | 1.990 |
Why?
|
Headache Disorders, Primary | 7 | 2021 | 39 | 1.960 |
Why?
|
Intracranial Arteriosclerosis | 5 | 2022 | 138 | 1.890 |
Why?
|
Cerebral Arterial Diseases | 5 | 2017 | 82 | 1.860 |
Why?
|
Cerebral Infarction | 7 | 2020 | 983 | 1.510 |
Why?
|
Oxygen Inhalation Therapy | 9 | 2016 | 411 | 1.440 |
Why?
|
Thrombectomy | 7 | 2024 | 705 | 1.330 |
Why?
|
Cerebral Hemorrhage | 12 | 2020 | 2656 | 1.270 |
Why?
|
Cerebral Arteries | 9 | 2013 | 490 | 1.250 |
Why?
|
Puerperal Disorders | 4 | 2019 | 300 | 1.200 |
Why?
|
Subarachnoid Hemorrhage | 9 | 2024 | 1033 | 1.120 |
Why?
|
Intracranial Arterial Diseases | 3 | 2019 | 22 | 1.110 |
Why?
|
Muscle Weakness | 2 | 2020 | 412 | 1.070 |
Why?
|
Paresis | 3 | 2021 | 176 | 1.010 |
Why?
|
Cerebrovascular Circulation | 11 | 2020 | 2727 | 0.990 |
Why?
|
Diffusion Magnetic Resonance Imaging | 16 | 2021 | 2791 | 0.910 |
Why?
|
Hyperbaric Oxygenation | 4 | 2008 | 165 | 0.840 |
Why?
|
Nervous System Diseases | 5 | 2022 | 1667 | 0.820 |
Why?
|
Endocarditis | 3 | 2021 | 348 | 0.780 |
Why?
|
Severity of Illness Index | 18 | 2024 | 15843 | 0.750 |
Why?
|
Glycyrrhiza | 2 | 2011 | 9 | 0.750 |
Why?
|
Neuroprotective Agents | 4 | 2019 | 957 | 0.750 |
Why?
|
Takayasu Arteritis | 1 | 2022 | 105 | 0.710 |
Why?
|
Headache | 9 | 2024 | 1256 | 0.710 |
Why?
|
Intracranial Hemorrhages | 5 | 2021 | 822 | 0.690 |
Why?
|
Hematoma, Subdural | 1 | 2020 | 127 | 0.660 |
Why?
|
Venous Thrombosis | 4 | 2024 | 1303 | 0.630 |
Why?
|
Brain Diseases | 7 | 2021 | 1546 | 0.610 |
Why?
|
Heparin | 3 | 2021 | 1634 | 0.610 |
Why?
|
Endovascular Procedures | 7 | 2024 | 2183 | 0.600 |
Why?
|
Infarction, Middle Cerebral Artery | 8 | 2021 | 485 | 0.600 |
Why?
|
Humans | 182 | 2024 | 761596 | 0.590 |
Why?
|
Brain | 32 | 2024 | 27121 | 0.580 |
Why?
|
Female | 124 | 2024 | 392705 | 0.580 |
Why?
|
Recurrence | 8 | 2023 | 8466 | 0.580 |
Why?
|
Magnetic Resonance Imaging | 41 | 2024 | 36426 | 0.570 |
Why?
|
Middle Aged | 89 | 2024 | 220921 | 0.560 |
Why?
|
Registries | 7 | 2018 | 8225 | 0.550 |
Why?
|
Propensity Score | 1 | 2024 | 1913 | 0.540 |
Why?
|
Metformin | 1 | 2024 | 906 | 0.540 |
Why?
|
Male | 121 | 2024 | 360846 | 0.540 |
Why?
|
Hyperoxia | 5 | 2005 | 258 | 0.540 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2021 | 513 | 0.530 |
Why?
|
Brain Edema | 7 | 2016 | 604 | 0.520 |
Why?
|
Coma | 7 | 2024 | 484 | 0.520 |
Why?
|
Vasomotor System | 1 | 2016 | 207 | 0.500 |
Why?
|
Brain Infarction | 8 | 2023 | 290 | 0.500 |
Why?
|
Tomography, X-Ray Computed | 22 | 2024 | 20568 | 0.500 |
Why?
|
Moyamoya Disease | 1 | 2019 | 265 | 0.500 |
Why?
|
Emergencies | 1 | 2022 | 1217 | 0.490 |
Why?
|
Eclampsia | 2 | 2021 | 56 | 0.490 |
Why?
|
Migraine Disorders | 3 | 2017 | 1703 | 0.480 |
Why?
|
Tissue Plasminogen Activator | 8 | 2016 | 1164 | 0.480 |
Why?
|
Anticoagulants | 7 | 2023 | 4812 | 0.470 |
Why?
|
International Cooperation | 4 | 2018 | 1422 | 0.470 |
Why?
|
Recovery of Function | 9 | 2021 | 2979 | 0.470 |
Why?
|
Hypoglycemic Agents | 3 | 2024 | 3085 | 0.460 |
Why?
|
Renal Artery Obstruction | 1 | 2015 | 219 | 0.460 |
Why?
|
Intracranial Thrombosis | 3 | 2024 | 108 | 0.460 |
Why?
|
Aged | 76 | 2024 | 169310 | 0.450 |
Why?
|
Muscle Strength | 1 | 2018 | 624 | 0.450 |
Why?
|
Quality of Health Care | 4 | 2018 | 4331 | 0.450 |
Why?
|
Cerebral Veins | 3 | 2017 | 157 | 0.440 |
Why?
|
Pregnancy Complications | 3 | 2019 | 2947 | 0.440 |
Why?
|
Foramen Ovale, Patent | 2 | 2013 | 208 | 0.430 |
Why?
|
Carotid Stenosis | 4 | 2018 | 860 | 0.430 |
Why?
|
Syndrome | 8 | 2024 | 3267 | 0.430 |
Why?
|
Acute Disease | 20 | 2024 | 7237 | 0.430 |
Why?
|
Diagnosis, Differential | 16 | 2024 | 12973 | 0.430 |
Why?
|
Atrial Fibrillation | 5 | 2023 | 5127 | 0.420 |
Why?
|
Unemployment | 1 | 2014 | 210 | 0.410 |
Why?
|
Thrombolytic Therapy | 8 | 2021 | 2064 | 0.410 |
Why?
|
Aged, 80 and over | 40 | 2024 | 58984 | 0.400 |
Why?
|
India | 6 | 2019 | 2348 | 0.400 |
Why?
|
Treatment Outcome | 32 | 2024 | 64685 | 0.390 |
Why?
|
Motor Cortex | 3 | 2018 | 1007 | 0.390 |
Why?
|
Endarterectomy, Carotid | 2 | 2007 | 555 | 0.380 |
Why?
|
Retrospective Studies | 36 | 2024 | 80647 | 0.380 |
Why?
|
Constriction, Pathologic | 2 | 2013 | 1096 | 0.370 |
Why?
|
Risk Factors | 26 | 2023 | 74213 | 0.360 |
Why?
|
Adult | 60 | 2022 | 221210 | 0.360 |
Why?
|
Thromboembolism | 3 | 2013 | 995 | 0.350 |
Why?
|
Arterial Occlusive Diseases | 3 | 2023 | 748 | 0.340 |
Why?
|
Carotid Artery, External | 1 | 2009 | 37 | 0.340 |
Why?
|
Carotid Artery, Internal, Dissection | 1 | 2009 | 42 | 0.330 |
Why?
|
Vascular System Injuries | 2 | 2023 | 246 | 0.330 |
Why?
|
Neurosurgical Procedures | 1 | 2020 | 2072 | 0.330 |
Why?
|
Oxygen | 8 | 2023 | 4227 | 0.310 |
Why?
|
Eligibility Determination | 1 | 2011 | 421 | 0.290 |
Why?
|
Frontal Lobe | 3 | 2018 | 1420 | 0.290 |
Why?
|
Glucocorticoids | 1 | 2016 | 2161 | 0.280 |
Why?
|
Reperfusion | 4 | 2010 | 271 | 0.280 |
Why?
|
Patient Selection | 4 | 2020 | 4244 | 0.280 |
Why?
|
Tomography Scanners, X-Ray Computed | 3 | 2014 | 173 | 0.280 |
Why?
|
Middle Cerebral Artery | 5 | 2020 | 275 | 0.270 |
Why?
|
Blast Crisis | 1 | 2007 | 102 | 0.270 |
Why?
|
Prognosis | 22 | 2022 | 29629 | 0.260 |
Why?
|
Vascular Diseases | 2 | 2005 | 1161 | 0.260 |
Why?
|
Collateral Circulation | 2 | 2021 | 294 | 0.260 |
Why?
|
Disease Progression | 12 | 2021 | 13510 | 0.260 |
Why?
|
Postpartum Period | 2 | 2021 | 1175 | 0.250 |
Why?
|
Electrocardiography, Ambulatory | 2 | 2022 | 578 | 0.250 |
Why?
|
Guillain-Barre Syndrome | 2 | 2005 | 127 | 0.250 |
Why?
|
Hypothermia, Induced | 2 | 2008 | 753 | 0.250 |
Why?
|
Psychotic Disorders | 1 | 2020 | 3223 | 0.250 |
Why?
|
Spinal Puncture | 1 | 2007 | 282 | 0.240 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2016 | 9001 | 0.240 |
Why?
|
Intracranial Embolism | 4 | 2020 | 189 | 0.240 |
Why?
|
Pre-Eclampsia | 2 | 2021 | 1231 | 0.240 |
Why?
|
Wakefulness | 2 | 2010 | 1265 | 0.240 |
Why?
|
Time Factors | 13 | 2022 | 39969 | 0.240 |
Why?
|
Hypoxia-Ischemia, Brain | 2 | 2012 | 352 | 0.230 |
Why?
|
Disability Evaluation | 3 | 2021 | 1836 | 0.220 |
Why?
|
Leukemia, Myeloid | 1 | 2007 | 694 | 0.220 |
Why?
|
Ultrasonography, Doppler, Transcranial | 4 | 2020 | 281 | 0.220 |
Why?
|
Predictive Value of Tests | 15 | 2020 | 15266 | 0.220 |
Why?
|
Thrombosis | 3 | 2021 | 2942 | 0.220 |
Why?
|
Warfarin | 3 | 2021 | 1483 | 0.220 |
Why?
|
Bartonella Infections | 1 | 2003 | 21 | 0.210 |
Why?
|
Muscle, Skeletal | 1 | 2018 | 4948 | 0.210 |
Why?
|
Magnetic Resonance Angiography | 6 | 2024 | 1432 | 0.210 |
Why?
|
Dementia, Vascular | 1 | 2004 | 122 | 0.210 |
Why?
|
Pyramidal Tracts | 2 | 2015 | 252 | 0.210 |
Why?
|
Upper Extremity | 3 | 2018 | 658 | 0.210 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 2024 | 110 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3086 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3206 | 0.200 |
Why?
|
Prospective Studies | 20 | 2023 | 54423 | 0.200 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2024 | 123 | 0.200 |
Why?
|
Carotid Artery Diseases | 3 | 2010 | 877 | 0.200 |
Why?
|
Heart Arrest | 5 | 2012 | 1514 | 0.190 |
Why?
|
Seizures | 3 | 2010 | 2957 | 0.190 |
Why?
|
Young Adult | 18 | 2020 | 59260 | 0.190 |
Why?
|
Hypoxia, Brain | 1 | 2002 | 138 | 0.190 |
Why?
|
Thiazoles | 2 | 2021 | 1517 | 0.190 |
Why?
|
Reflex | 1 | 2003 | 376 | 0.190 |
Why?
|
Serotonin Receptor Agonists | 1 | 2002 | 151 | 0.180 |
Why?
|
Embolism, Paradoxical | 1 | 2021 | 54 | 0.180 |
Why?
|
Mental Disorders | 1 | 2021 | 6845 | 0.180 |
Why?
|
Clinical Trials as Topic | 4 | 2014 | 8002 | 0.180 |
Why?
|
Hyperglycemia | 2 | 2009 | 1376 | 0.180 |
Why?
|
Cross-Over Studies | 2 | 2017 | 2079 | 0.180 |
Why?
|
Chickenpox | 1 | 2001 | 96 | 0.180 |
Why?
|
Clinical Protocols | 2 | 2018 | 1440 | 0.180 |
Why?
|
Sagittal Sinus Thrombosis | 1 | 1999 | 11 | 0.170 |
Why?
|
Pregnancy | 6 | 2021 | 29890 | 0.170 |
Why?
|
Liver Cirrhosis, Alcoholic | 1 | 1999 | 64 | 0.170 |
Why?
|
Patient Transfer | 2 | 2020 | 794 | 0.170 |
Why?
|
Immunologic Factors | 2 | 2020 | 1590 | 0.160 |
Why?
|
Ankle Joint | 1 | 2003 | 446 | 0.160 |
Why?
|
Confusion | 1 | 2021 | 278 | 0.160 |
Why?
|
Long QT Syndrome | 1 | 2023 | 467 | 0.160 |
Why?
|
Delusions | 1 | 2021 | 298 | 0.160 |
Why?
|
After-Hours Care | 1 | 2020 | 102 | 0.160 |
Why?
|
Encephalitis | 1 | 2003 | 440 | 0.160 |
Why?
|
Quadriplegia | 2 | 2003 | 226 | 0.160 |
Why?
|
Heart Neoplasms | 1 | 2022 | 362 | 0.160 |
Why?
|
Sleep | 2 | 2020 | 4768 | 0.160 |
Why?
|
Social Planning | 1 | 2018 | 9 | 0.150 |
Why?
|
Drug Administration Routes | 2 | 2016 | 150 | 0.150 |
Why?
|
Hypertension | 6 | 2020 | 8540 | 0.150 |
Why?
|
Rupture, Spontaneous | 1 | 2018 | 362 | 0.150 |
Why?
|
Leukoaraiosis | 2 | 2009 | 116 | 0.140 |
Why?
|
China | 3 | 2018 | 2374 | 0.140 |
Why?
|
Pyridines | 3 | 2021 | 2875 | 0.140 |
Why?
|
Carotid Artery Injuries | 1 | 1998 | 96 | 0.140 |
Why?
|
Status Epilepticus | 1 | 2003 | 460 | 0.140 |
Why?
|
Adolescent | 19 | 2020 | 88326 | 0.140 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2007 | 3769 | 0.140 |
Why?
|
Hemoglobinuria, Paroxysmal | 1 | 2017 | 94 | 0.140 |
Why?
|
Causality | 5 | 2011 | 1242 | 0.140 |
Why?
|
Fatal Outcome | 3 | 2009 | 1835 | 0.130 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2018 | 362 | 0.130 |
Why?
|
Motor Activity | 3 | 2018 | 2715 | 0.130 |
Why?
|
Fibrinolytic Agents | 3 | 2016 | 2084 | 0.130 |
Why?
|
Natural Language Processing | 1 | 2024 | 1163 | 0.130 |
Why?
|
Cohort Studies | 12 | 2018 | 41495 | 0.130 |
Why?
|
Neuronal Plasticity | 4 | 2013 | 1436 | 0.130 |
Why?
|
Functional Laterality | 4 | 2012 | 2257 | 0.130 |
Why?
|
Logistic Models | 6 | 2023 | 13255 | 0.120 |
Why?
|
Methylprednisolone | 1 | 2016 | 385 | 0.120 |
Why?
|
Perfusion | 2 | 2012 | 1373 | 0.120 |
Why?
|
Critical Pathways | 1 | 2019 | 474 | 0.120 |
Why?
|
Regression Analysis | 5 | 2016 | 6345 | 0.120 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2021 | 518 | 0.120 |
Why?
|
Diabetes Complications | 2 | 2020 | 1315 | 0.120 |
Why?
|
Embolism | 1 | 2018 | 399 | 0.120 |
Why?
|
Rats | 13 | 2013 | 23741 | 0.120 |
Why?
|
Comorbidity | 6 | 2017 | 10508 | 0.120 |
Why?
|
Antifungal Agents | 1 | 2019 | 753 | 0.120 |
Why?
|
Vertebral Artery | 1 | 1995 | 185 | 0.120 |
Why?
|
Heart Valve Diseases | 1 | 2022 | 1027 | 0.120 |
Why?
|
Leukocyte Count | 1 | 2018 | 1596 | 0.120 |
Why?
|
Movement | 2 | 2014 | 1478 | 0.110 |
Why?
|
Patient Admission | 2 | 2020 | 1367 | 0.110 |
Why?
|
Blood Volume | 2 | 2012 | 547 | 0.110 |
Why?
|
Risk Assessment | 8 | 2020 | 23996 | 0.110 |
Why?
|
Rats, Sprague-Dawley | 9 | 2018 | 8181 | 0.110 |
Why?
|
Glyburide | 1 | 2014 | 116 | 0.110 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2006 | 3246 | 0.110 |
Why?
|
Mandible | 1 | 1998 | 753 | 0.110 |
Why?
|
Case-Control Studies | 5 | 2020 | 22176 | 0.100 |
Why?
|
Hospital Mortality | 4 | 2021 | 5293 | 0.100 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2021 | 942 | 0.100 |
Why?
|
Vision Disorders | 4 | 2017 | 1088 | 0.100 |
Why?
|
Aspirin | 2 | 2022 | 3133 | 0.100 |
Why?
|
Matrix Metalloproteinase 9 | 2 | 2014 | 632 | 0.100 |
Why?
|
Intracranial Aneurysm | 1 | 2002 | 1285 | 0.100 |
Why?
|
Osteotomy | 1 | 1998 | 837 | 0.100 |
Why?
|
Arteriovenous Malformations | 1 | 1995 | 396 | 0.100 |
Why?
|
Managed Care Programs | 1 | 2018 | 940 | 0.100 |
Why?
|
Cesarean Section | 1 | 2021 | 1398 | 0.100 |
Why?
|
Basilar Artery | 2 | 2012 | 205 | 0.100 |
Why?
|
Emergency Service, Hospital | 3 | 2022 | 7879 | 0.100 |
Why?
|
Hematologic Tests | 1 | 2013 | 239 | 0.100 |
Why?
|
Rats, Wistar | 2 | 2012 | 1848 | 0.100 |
Why?
|
Hospitals | 3 | 2019 | 3883 | 0.090 |
Why?
|
Blood Gas Analysis | 1 | 2012 | 379 | 0.090 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2850 | 0.090 |
Why?
|
Nimodipine | 1 | 2010 | 56 | 0.090 |
Why?
|
Disease Management | 2 | 2019 | 2508 | 0.090 |
Why?
|
Drug Administration Schedule | 1 | 2019 | 4853 | 0.090 |
Why?
|
Secondary Prevention | 2 | 2016 | 1475 | 0.090 |
Why?
|
Physician's Role | 1 | 2017 | 917 | 0.090 |
Why?
|
Pandemics | 2 | 2021 | 8656 | 0.090 |
Why?
|
Telemedicine | 2 | 2021 | 3052 | 0.090 |
Why?
|
Heart Rate | 1 | 2022 | 4195 | 0.090 |
Why?
|
Verapamil | 1 | 2010 | 242 | 0.090 |
Why?
|
Multivariate Analysis | 4 | 2014 | 12059 | 0.090 |
Why?
|
Gravitation | 1 | 2009 | 82 | 0.080 |
Why?
|
Neurology | 1 | 2017 | 780 | 0.080 |
Why?
|
Administration, Oral | 2 | 2023 | 4021 | 0.080 |
Why?
|
Electronic Health Records | 2 | 2024 | 4811 | 0.080 |
Why?
|
Triage | 1 | 2016 | 986 | 0.080 |
Why?
|
Databases, Factual | 3 | 2020 | 7968 | 0.080 |
Why?
|
Prevalence | 5 | 2018 | 15733 | 0.080 |
Why?
|
Vasoconstrictor Agents | 2 | 2004 | 654 | 0.080 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2019 | 1553 | 0.080 |
Why?
|
Robotics | 2 | 2013 | 819 | 0.080 |
Why?
|
Aphasia | 1 | 2010 | 192 | 0.080 |
Why?
|
Cardiomyopathies | 1 | 2021 | 1964 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2021 | 2751 | 0.080 |
Why?
|
Critical Care | 2 | 2020 | 2697 | 0.080 |
Why?
|
Heparin, Low-Molecular-Weight | 2 | 2021 | 344 | 0.080 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2010 | 190 | 0.080 |
Why?
|
Hemodynamics | 3 | 2020 | 4160 | 0.080 |
Why?
|
Diffusion Tensor Imaging | 2 | 2015 | 2400 | 0.070 |
Why?
|
Carotid Artery, Internal | 1 | 2010 | 445 | 0.070 |
Why?
|
Vertebrobasilar Insufficiency | 1 | 2008 | 113 | 0.070 |
Why?
|
Iodine | 1 | 2009 | 288 | 0.070 |
Why?
|
Mortality | 2 | 2016 | 2902 | 0.070 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6815 | 0.070 |
Why?
|
Disease Models, Animal | 8 | 2018 | 18255 | 0.070 |
Why?
|
Spinal Cord | 1 | 1995 | 1819 | 0.070 |
Why?
|
Arteries | 2 | 2022 | 1123 | 0.070 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2014 | 1116 | 0.070 |
Why?
|
Vasculitis | 1 | 2011 | 521 | 0.070 |
Why?
|
Double-Blind Method | 5 | 2021 | 12341 | 0.070 |
Why?
|
Analysis of Variance | 3 | 2010 | 6228 | 0.070 |
Why?
|
United States | 7 | 2022 | 72340 | 0.070 |
Why?
|
Pilot Projects | 3 | 2014 | 8633 | 0.070 |
Why?
|
International Normalized Ratio | 1 | 2008 | 382 | 0.070 |
Why?
|
Plaque, Atherosclerotic | 1 | 2018 | 1532 | 0.070 |
Why?
|
Follow-Up Studies | 6 | 2016 | 39106 | 0.070 |
Why?
|
Anatomy, Artistic | 1 | 2006 | 51 | 0.070 |
Why?
|
Animals | 18 | 2018 | 168475 | 0.070 |
Why?
|
Sex Factors | 2 | 2019 | 10554 | 0.070 |
Why?
|
Telencephalon | 1 | 2007 | 142 | 0.070 |
Why?
|
Diabetic Angiopathies | 1 | 2011 | 803 | 0.070 |
Why?
|
Vasodilator Agents | 1 | 2010 | 973 | 0.070 |
Why?
|
Haloperidol | 1 | 1988 | 389 | 0.070 |
Why?
|
Energy Metabolism | 2 | 2007 | 2882 | 0.070 |
Why?
|
Medical Illustration | 1 | 2006 | 135 | 0.060 |
Why?
|
Education, Medical | 1 | 2017 | 1725 | 0.060 |
Why?
|
Leukocytosis | 1 | 2007 | 251 | 0.060 |
Why?
|
Nitric Oxide Donors | 1 | 2006 | 126 | 0.060 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2015 | 3359 | 0.060 |
Why?
|
Dilatation, Pathologic | 1 | 2007 | 527 | 0.060 |
Why?
|
Blood-Brain Barrier | 2 | 2002 | 1027 | 0.060 |
Why?
|
Diagnosis, Computer-Assisted | 2 | 2007 | 710 | 0.060 |
Why?
|
Odds Ratio | 5 | 2021 | 9647 | 0.060 |
Why?
|
Heart Diseases | 1 | 2018 | 2781 | 0.060 |
Why?
|
Accident Proneness | 1 | 2004 | 4 | 0.060 |
Why?
|
Thrombocytopenia | 2 | 2017 | 1182 | 0.060 |
Why?
|
Aspartic Acid | 1 | 2007 | 576 | 0.060 |
Why?
|
Chronic Disease | 2 | 2017 | 9319 | 0.060 |
Why?
|
Survival Rate | 2 | 2017 | 12723 | 0.060 |
Why?
|
Immunosuppressive Agents | 2 | 2014 | 4176 | 0.060 |
Why?
|
Neurocysticercosis | 1 | 2006 | 91 | 0.060 |
Why?
|
Emergency Medical Services | 1 | 2016 | 1923 | 0.060 |
Why?
|
Models, Animal | 2 | 2011 | 2112 | 0.060 |
Why?
|
Adenocarcinoma | 1 | 2002 | 6345 | 0.060 |
Why?
|
Angiography | 1 | 2009 | 1595 | 0.060 |
Why?
|
Decision Support Techniques | 1 | 2014 | 1998 | 0.060 |
Why?
|
Inpatients | 1 | 2015 | 2548 | 0.060 |
Why?
|
Intracranial Pressure | 1 | 2006 | 324 | 0.060 |
Why?
|
Cranial Sinuses | 1 | 2024 | 68 | 0.060 |
Why?
|
Head | 1 | 2009 | 924 | 0.060 |
Why?
|
Anti-Bacterial Agents | 2 | 2019 | 7406 | 0.050 |
Why?
|
Laser-Doppler Flowmetry | 3 | 2011 | 239 | 0.050 |
Why?
|
Colitis, Ulcerative | 1 | 1995 | 1922 | 0.050 |
Why?
|
Patient Care Planning | 1 | 2008 | 909 | 0.050 |
Why?
|
Crohn Disease | 1 | 1995 | 2279 | 0.050 |
Why?
|
Blood Glucose | 2 | 2009 | 6391 | 0.050 |
Why?
|
Hydrocortisone | 1 | 2010 | 1819 | 0.050 |
Why?
|
Calcium Channel Blockers | 1 | 2006 | 694 | 0.050 |
Why?
|
Observer Variation | 4 | 2012 | 2606 | 0.050 |
Why?
|
Protein Denaturation | 1 | 2002 | 242 | 0.050 |
Why?
|
Lactic Acid | 1 | 2007 | 1139 | 0.050 |
Why?
|
Corpus Callosum | 1 | 2007 | 751 | 0.050 |
Why?
|
Cerebral Cortex | 3 | 2011 | 5779 | 0.050 |
Why?
|
Ephedrine | 1 | 2002 | 52 | 0.050 |
Why?
|
Heme Oxygenase (Decyclizing) | 1 | 2002 | 167 | 0.050 |
Why?
|
Review Literature as Topic | 1 | 2004 | 348 | 0.050 |
Why?
|
Lung | 1 | 2020 | 10002 | 0.050 |
Why?
|
Schizophrenia | 1 | 2020 | 6937 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2006 | 2273 | 0.050 |
Why?
|
Infarction | 1 | 2023 | 248 | 0.050 |
Why?
|
Regional Blood Flow | 1 | 2005 | 1496 | 0.050 |
Why?
|
Patient Readmission | 1 | 2015 | 3271 | 0.050 |
Why?
|
Hospitalization | 2 | 2018 | 10721 | 0.050 |
Why?
|
Huntington Disease | 1 | 1988 | 1144 | 0.050 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2023 | 629 | 0.050 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2005 | 664 | 0.040 |
Why?
|
Infusions, Intravenous | 3 | 2014 | 2217 | 0.040 |
Why?
|
Craniotomy | 1 | 2004 | 741 | 0.040 |
Why?
|
Brain Injuries | 2 | 2002 | 2054 | 0.040 |
Why?
|
Age Distribution | 4 | 2011 | 2879 | 0.040 |
Why?
|
Inflammation | 1 | 2020 | 10774 | 0.040 |
Why?
|
Heme Oxygenase-1 | 1 | 2002 | 366 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 10212 | 0.040 |
Why?
|
Hippocampus | 1 | 2012 | 3766 | 0.040 |
Why?
|
Cerebellum | 3 | 2013 | 1501 | 0.040 |
Why?
|
Data Mining | 1 | 2024 | 551 | 0.040 |
Why?
|
Electrocardiography | 1 | 2013 | 6377 | 0.040 |
Why?
|
Hemorrhage | 2 | 2021 | 3424 | 0.040 |
Why?
|
Contrast Sensitivity | 1 | 2001 | 253 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2017 | 5841 | 0.040 |
Why?
|
American Heart Association | 1 | 2024 | 1039 | 0.040 |
Why?
|
Movement Disorders | 2 | 2015 | 459 | 0.040 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2006 | 1516 | 0.040 |
Why?
|
Sensitivity and Specificity | 5 | 2016 | 14665 | 0.040 |
Why?
|
Kidney Diseases | 1 | 2009 | 2091 | 0.040 |
Why?
|
Quality of Life | 2 | 2023 | 13367 | 0.040 |
Why?
|
Glycopeptides | 1 | 2000 | 220 | 0.040 |
Why?
|
Phlebography | 1 | 1999 | 326 | 0.040 |
Why?
|
Troponin T | 1 | 2023 | 780 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1702 | 0.040 |
Why?
|
Length of Stay | 2 | 2018 | 6426 | 0.040 |
Why?
|
Carotid Artery Thrombosis | 1 | 1998 | 50 | 0.040 |
Why?
|
Prognathism | 1 | 1998 | 26 | 0.040 |
Why?
|
Intracranial Embolism and Thrombosis | 1 | 1998 | 144 | 0.040 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2023 | 851 | 0.040 |
Why?
|
Recombinant Proteins | 2 | 2013 | 6534 | 0.040 |
Why?
|
New England | 1 | 2021 | 1054 | 0.040 |
Why?
|
Asia, Western | 1 | 2017 | 18 | 0.040 |
Why?
|
Bone Marrow Examination | 1 | 2017 | 155 | 0.040 |
Why?
|
Heart Atria | 1 | 2023 | 1345 | 0.040 |
Why?
|
Diagnostic Imaging | 2 | 2011 | 3530 | 0.040 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2017 | 186 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2002 | 1246 | 0.040 |
Why?
|
Anemia, Hemolytic | 1 | 2017 | 162 | 0.030 |
Why?
|
Poisoning | 1 | 1998 | 252 | 0.030 |
Why?
|
Gene Targeting | 1 | 2000 | 838 | 0.030 |
Why?
|
PubMed | 1 | 2017 | 129 | 0.030 |
Why?
|
Blood Coagulation Disorders | 1 | 1999 | 350 | 0.030 |
Why?
|
Ischemia | 1 | 2005 | 1884 | 0.030 |
Why?
|
Massachusetts | 2 | 2024 | 8833 | 0.030 |
Why?
|
Aminosalicylic Acids | 1 | 1995 | 37 | 0.030 |
Why?
|
Echocardiography, Transesophageal | 1 | 2002 | 1086 | 0.030 |
Why?
|
Corpus Striatum | 1 | 2002 | 1235 | 0.030 |
Why?
|
Child | 6 | 2011 | 80158 | 0.030 |
Why?
|
Lipoxygenase Inhibitors | 1 | 1995 | 93 | 0.030 |
Why?
|
Sex Distribution | 3 | 2011 | 2280 | 0.030 |
Why?
|
Central Nervous System | 1 | 2022 | 1336 | 0.030 |
Why?
|
Treatment Failure | 1 | 2021 | 2643 | 0.030 |
Why?
|
Microcirculation | 2 | 2011 | 1272 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2002 | 1486 | 0.030 |
Why?
|
Mesalamine | 1 | 1995 | 135 | 0.030 |
Why?
|
Blood Coagulation | 1 | 2021 | 1154 | 0.030 |
Why?
|
Reproducibility of Results | 5 | 2014 | 20100 | 0.030 |
Why?
|
Embolization, Therapeutic | 1 | 2004 | 1418 | 0.030 |
Why?
|
Maxilla | 1 | 1998 | 494 | 0.030 |
Why?
|
Kinetics | 1 | 2002 | 6374 | 0.030 |
Why?
|
Aging | 2 | 2011 | 8710 | 0.030 |
Why?
|
Radiography, Abdominal | 1 | 2017 | 534 | 0.030 |
Why?
|
Insulin | 1 | 2009 | 6597 | 0.030 |
Why?
|
Emigration and Immigration | 1 | 2017 | 397 | 0.030 |
Why?
|
Rehabilitation Centers | 1 | 2015 | 246 | 0.030 |
Why?
|
Angiography, Digital Subtraction | 1 | 1995 | 335 | 0.030 |
Why?
|
Nutritional Support | 1 | 1995 | 173 | 0.030 |
Why?
|
Rupture | 1 | 1995 | 443 | 0.030 |
Why?
|
Mitral Valve | 1 | 2022 | 1465 | 0.030 |
Why?
|
Biopsy | 2 | 2019 | 6766 | 0.030 |
Why?
|
Antidepressive Agents | 1 | 2006 | 2897 | 0.030 |
Why?
|
North America | 1 | 2017 | 1276 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2005 | 3688 | 0.030 |
Why?
|
Suicide | 2 | 2002 | 1602 | 0.030 |
Why?
|
Neurologic Examination | 2 | 2009 | 916 | 0.030 |
Why?
|
Epilepsy | 1 | 2008 | 3290 | 0.030 |
Why?
|
Suicide, Attempted | 1 | 2002 | 1402 | 0.030 |
Why?
|
Calibration | 1 | 2015 | 818 | 0.030 |
Why?
|
Patient Discharge | 2 | 2016 | 3443 | 0.030 |
Why?
|
Peptic Ulcer | 1 | 2014 | 217 | 0.030 |
Why?
|
Algorithms | 3 | 2009 | 14033 | 0.030 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2009 | 952 | 0.030 |
Why?
|
Dysarthria | 1 | 2012 | 58 | 0.030 |
Why?
|
Electroencephalography | 1 | 2008 | 6237 | 0.030 |
Why?
|
Incidence | 4 | 2017 | 21355 | 0.020 |
Why?
|
Radiography | 2 | 2013 | 6965 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 2004 | 2492 | 0.020 |
Why?
|
Spleen | 1 | 2017 | 2295 | 0.020 |
Why?
|
Developing Countries | 2 | 2008 | 2885 | 0.020 |
Why?
|
Brain Mapping | 1 | 2006 | 6635 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2017 | 1071 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2002 | 3113 | 0.020 |
Why?
|
Water | 2 | 2011 | 1411 | 0.020 |
Why?
|
Veins | 1 | 1995 | 768 | 0.020 |
Why?
|
Hand Strength | 1 | 2014 | 456 | 0.020 |
Why?
|
Child, Preschool | 4 | 2008 | 42232 | 0.020 |
Why?
|
Neck | 1 | 1995 | 734 | 0.020 |
Why?
|
Emigrants and Immigrants | 1 | 2017 | 543 | 0.020 |
Why?
|
Age Factors | 3 | 2015 | 18399 | 0.020 |
Why?
|
Anisotropy | 1 | 2014 | 1283 | 0.020 |
Why?
|
Steroids | 1 | 1995 | 929 | 0.020 |
Why?
|
Europe | 1 | 2017 | 3420 | 0.020 |
Why?
|
Ataxia | 1 | 2012 | 306 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2630 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2007 | 7391 | 0.020 |
Why?
|
Random Allocation | 1 | 2014 | 2395 | 0.020 |
Why?
|
Echocardiography | 1 | 2002 | 4989 | 0.020 |
Why?
|
Rats, Inbred SHR | 1 | 2009 | 186 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2002 | 4415 | 0.020 |
Why?
|
Hepatitis C | 1 | 1999 | 1584 | 0.020 |
Why?
|
Brain Damage, Chronic | 1 | 2010 | 267 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 8527 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10090 | 0.020 |
Why?
|
Critical Illness | 1 | 2021 | 2723 | 0.020 |
Why?
|
Perfusion Imaging | 1 | 2010 | 196 | 0.020 |
Why?
|
Anemia | 1 | 2017 | 1509 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10766 | 0.020 |
Why?
|
Hospitals, University | 1 | 2010 | 564 | 0.020 |
Why?
|
Neuroradiography | 1 | 2008 | 71 | 0.020 |
Why?
|
Disopyramide | 1 | 1987 | 16 | 0.020 |
Why?
|
Basal Ganglia | 1 | 2011 | 554 | 0.020 |
Why?
|
Liver Transplantation | 1 | 1999 | 2330 | 0.020 |
Why?
|
Radioligand Assay | 1 | 1988 | 366 | 0.020 |
Why?
|
Infant | 2 | 2008 | 36193 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2008 | 9032 | 0.020 |
Why?
|
Iopamidol | 1 | 2007 | 186 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 1988 | 659 | 0.020 |
Why?
|
Models, Statistical | 2 | 2014 | 5079 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2010 | 1574 | 0.020 |
Why?
|
Gonadal Steroid Hormones | 1 | 2010 | 702 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 1995 | 1809 | 0.020 |
Why?
|
Anemia, Sickle Cell | 1 | 1994 | 1063 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2009 | 793 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2015 | 26129 | 0.020 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2011 | 1119 | 0.020 |
Why?
|
Blood Pressure | 1 | 2020 | 8481 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2007 | 15633 | 0.010 |
Why?
|
Liver | 1 | 2000 | 7528 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2007 | 13642 | 0.010 |
Why?
|
Liver Cirrhosis | 1 | 2014 | 1935 | 0.010 |
Why?
|
Atmospheric Pressure | 1 | 2003 | 46 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2015 | 3575 | 0.010 |
Why?
|
Ontario | 1 | 2004 | 398 | 0.010 |
Why?
|
Hand | 1 | 2009 | 903 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2013 | 2319 | 0.010 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2005 | 459 | 0.010 |
Why?
|
Forelimb | 1 | 2003 | 116 | 0.010 |
Why?
|
Neurons | 1 | 2002 | 9463 | 0.010 |
Why?
|
Health Status | 1 | 2015 | 4077 | 0.010 |
Why?
|
Amyloidosis | 1 | 2008 | 817 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2008 | 1530 | 0.010 |
Why?
|
Hypercapnia | 1 | 2003 | 261 | 0.010 |
Why?
|
Data Collection | 1 | 2010 | 3322 | 0.010 |
Why?
|
Injury Severity Score | 1 | 2004 | 1045 | 0.010 |
Why?
|
Models, Neurological | 1 | 2009 | 1769 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2011 | 2639 | 0.010 |
Why?
|
Chloramphenicol O-Acetyltransferase | 1 | 2000 | 221 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2006 | 2358 | 0.010 |
Why?
|
Sample Size | 1 | 2003 | 841 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2017 | 5337 | 0.010 |
Why?
|
ROC Curve | 1 | 2007 | 3578 | 0.010 |
Why?
|
Probability | 1 | 2004 | 2477 | 0.010 |
Why?
|
Pain | 1 | 1994 | 5073 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 2691 | 0.010 |
Why?
|
Trauma Centers | 1 | 2004 | 937 | 0.010 |
Why?
|
Flavonoids | 1 | 2002 | 445 | 0.010 |
Why?
|
Anticonvulsants | 1 | 2008 | 1906 | 0.010 |
Why?
|
Safety | 1 | 2003 | 1149 | 0.010 |
Why?
|
Organ Size | 1 | 2003 | 2254 | 0.010 |
Why?
|
Neural Pathways | 1 | 2009 | 3060 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2011 | 11076 | 0.010 |
Why?
|
Clinical Competence | 1 | 2013 | 4793 | 0.010 |
Why?
|
Medicare | 1 | 2015 | 6770 | 0.010 |
Why?
|
Linear Models | 1 | 2007 | 5872 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2011 | 3415 | 0.010 |
Why?
|
Urban Population | 1 | 2004 | 2036 | 0.010 |
Why?
|
Imidazoles | 1 | 2002 | 1180 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2002 | 18966 | 0.010 |
Why?
|
Plasmids | 1 | 2000 | 2269 | 0.010 |
Why?
|
Behavior, Animal | 1 | 2003 | 1878 | 0.010 |
Why?
|
Skinfold Thickness | 1 | 1994 | 162 | 0.010 |
Why?
|
Contrast Media | 1 | 2007 | 5307 | 0.010 |
Why?
|
Pharmaceutical Preparations | 1 | 2001 | 1089 | 0.010 |
Why?
|
Cardiovascular Diseases | 2 | 2010 | 15502 | 0.010 |
Why?
|
Urination Disorders | 1 | 1994 | 238 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2003 | 5247 | 0.010 |
Why?
|
Primary Health Care | 1 | 2008 | 4687 | 0.010 |
Why?
|
Cell Survival | 1 | 2002 | 5791 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2002 | 3713 | 0.010 |
Why?
|
Menstrual Cycle | 1 | 1994 | 539 | 0.010 |
Why?
|
Bone Diseases | 1 | 1994 | 418 | 0.010 |
Why?
|
Cold Temperature | 1 | 1994 | 785 | 0.010 |
Why?
|
Cough | 1 | 1994 | 594 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2008 | 26202 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 2000 | 13446 | 0.000 |
Why?
|
Chi-Square Distribution | 1 | 1994 | 3415 | 0.000 |
Why?
|
Research Design | 1 | 2003 | 6180 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 2000 | 17635 | 0.000 |
Why?
|
Gene Expression | 1 | 2000 | 7581 | 0.000 |
Why?
|
Fever | 1 | 1994 | 1618 | 0.000 |
Why?
|
Tachycardia | 1 | 1987 | 600 | 0.000 |
Why?
|
Pulmonary Edema | 1 | 1987 | 409 | 0.000 |
Why?
|
Mice | 2 | 2002 | 81539 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2002 | 22174 | 0.000 |
Why?
|
Ambulatory Care | 1 | 1994 | 2775 | 0.000 |
Why?
|
Patient Acceptance of Health Care | 1 | 1994 | 3206 | 0.000 |
Why?
|